Inventor · disambiguated record
Soo Bong Han
Also filed as: HAN SOO BONG
8 granted patents·7 pending applications·13 citations·filing 2012–2024
81Inventor score
Files withKOREA RES INST CHEMICAL TECH5NOVARTIS AG4AM SCIENCES INC2JUNG YOUNG SIK2KANAPH THERAPEUTICS INC2
Top patents by PatentIndex Score
15 records- 0176US9951058B2Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2017·Granted Apr 24, 2018·2 cites·14 claims
- 0275US9890133B2Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseasesKOREA RES INST CHEMICAL TECH·Filed 2016·Granted Feb 13, 2018·2 cites·18 claims
- 0373US9833423B21,3-Di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredientKOREA RES INST CHEMICAL TECH·Filed 2016·Granted Dec 5, 2017·2 cites·18 claims
- 0472US9790197B2Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredientKOREA RES INST CHEMICAL TECH·Filed 2013·Granted Oct 17, 2017·2 cites·4 claims
- 0572US9464067B2Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseasesJUNG YOUNG SIK·Filed 2012·Granted Oct 11, 2016·3 cites·19 claims
- 0672US2025188066A1Antiviral 1,3-di-oxo-indene compoundsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0770US2025090491A1Antiviral 1,3-di-oxo-indene compoundsNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0869US9346749B21,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredientJUNG YOUNG SIK·Filed 2012·Granted May 24, 2016·2 cites·20 claims
- 0965US12286423B2Antiviral 1,3-di-oxo-indene compoundsNOVARTIS AG·Filed 2021·Granted Apr 29, 2025·0 cites·4 claims
- 1065US12083092B2Antiviral 1,3-di-oxo-indene compoundsNOVARTIS AG·Filed 2021·Granted Sep 10, 2024·0 cites·31 claims
- 1150US2023248734A1Antiviral composition obtained through drug repositioningKOREA RES INST CHEMICAL TECH·Filed 2021·Application pending·0 cites
- 1250US2025161271A1Pharmaceutical composition for treating cancer, comprising anticancer agent and novel compound having inhibitory activity with respect to prostaglandin e2 receptorsKANAPH THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1348US2025235462A1Novel capsid assembly inhibitorsAM SCIENCES INC·Filed 2022·Application pending·0 cites
- 1448US2025009742A1Novel capsid assembly inhibitorsAM SCIENCES INC·Filed 2022·Application pending·0 cites
- 1542US2023365582A1Novel compounds having inhibitory activity on prostaglandin e2 receptor and uses thereofKANAPH THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →